Merrimack Pharmaceuticals Analysis
| MACKDelisted Stock | USD 11.96 0.12 1.01% |
Merrimack Pharmaceuticals is overvalued with Real Value of 10.33 and Hype Value of 11.96. The main objective of Merrimack Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Merrimack Pharmaceuticals is worth, separate from its market price. There are two main types of Merrimack Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Merrimack Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Merrimack |
Merrimack Stock Analysis Notes
About 63.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.07. Merrimack Pharmaceuticals recorded a loss per share of 0.09. The entity last dividend was issued on the 9th of May 2024. The firm had 1271:1000 split on the 6th of September 2019. Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Merrimack Pharmaceuticals contact the company at 617 720 8606 or learn more at https://www.merrimack.com.Merrimack Pharmaceuticals Investment Alerts
| Merrimack Pharmaceuticals is not yet fully synchronised with the market data | |
| Merrimack Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (1.18 M) with loss before overhead, payroll, taxes, and interest of (9.1 M). | |
| Merrimack Pharmaceuticals currently holds about 13.36 M in cash with (1.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Merrimack Pharmaceuticals Upcoming and Recent Events
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Merrimack Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 223.75 M.Merrimack Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Merrimack Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Merrimack Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Merrimack Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Levy Noah G. over six months ago Acquisition by Levy Noah G. of 1300 shares of Merrimack Pharmaceuticals at 11.2423 subject to Rule 16b-3 | ||
Gary Crocker over six months ago Acquisition by Gary Crocker of 8000 shares of Merrimack Pharmaceuticals subject to Rule 16b-3 | ||
Andersen Eric over six months ago Acquisition by Andersen Eric of 2165 shares of Merrimack Pharmaceuticals at 12.1923 subject to Rule 16b-3 | ||
William Sullivan over a year ago Acquisition by William Sullivan of 60000 shares of Merrimack Pharmaceuticals subject to Rule 16b-3 |
Merrimack Pharmaceuticals Outstanding Bonds
Merrimack Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Merrimack Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Merrimack bonds can be classified according to their maturity, which is the date when Merrimack Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Merrimack Pharmaceuticals Predictive Daily Indicators
Merrimack Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Merrimack Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Merrimack Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Merrimack Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Merrimack shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Merrimack Pharmaceuticals. By using and applying Merrimack Stock analysis, traders can create a robust methodology for identifying Merrimack entry and exit points for their positions.
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Merrimack Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Merrimack Stock
If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |